MDNA.TO MEDICENNA THERAPEUTICS CORP
$0.42▼ -1.19%
Healthcare
Other
Volume 24.9K
Avg Volume (10D) 42.6K
Key Metrics & Fundamentals
Market Cap
$38.30M
P/E Ratio
–
Div Yield
–%
52W Range
0.34 - 1.97
% vs 50 MA
4.84%
% vs 200 MA
-39.25%
RSI-14
45.4
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.89
Free Cash Flow
-$4.48M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$7.34M
COGS
–
Operating Exp
$5.82M
Operating Income
-$5.82M
EBIT
-$5.82M
Pretax Income
-$4.23M
Net Income
-$4.23M
Price & Volume History
Loading chart…
Recent News
Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 3, 2026 11:00 AM
Medicenna Q2 Net Loss Flat at C$0.06 Per Share
MT Newswires · Aug 14, 2026 5:21 PM
Medicenna Therapeutics Reports First Quarter Fiscal 2027 Financial Results and Announces Oral Presentations at Upcoming Conferences
GlobeNewswire · Aug 14, 2026 11:00 AM
Medicenna Therapeutics Fiscal 2026 Loss Widens
MT Newswires · Jun 26, 2026 1:47 PM
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
GlobeNewswire · Jun 26, 2026 12:45 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MDNA.TO's money flow as a full page
Social Sentiment
No Reddit posts found for MDNA.TO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.